Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GE HealthCare Technologies Inc. - Common Stock (NQ: GEHC )

91.62 +0.59 (+0.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,334,119
Open 91.05
Bid (Size) 90.00 (4)
Ask (Size) 91.58 (4)
Prev. Close 91.03
Today's Range 90.57 - 91.80
52wk Range 62.35 - 94.55
Shares Outstanding N/A
Dividend Yield 0.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
From GE HealthCare
Via Business Wire
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Reddit, which went public earlier this year. 
Via Benzinga

Performance

YTD
+19.97%
+19.97%
1 Month
+5.42%
+5.42%
3 Month
+14.25%
+14.25%
6 Month
+6.37%
+6.37%
1 Year
+36.99%
+36.99%

More News

Read More
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
From GE HealthCare
Via Business Wire
Analyst Scoreboard: 4 Ratings For GE HealthCare Techs
Via Benzinga
How Is The Market Feeling About GE HealthCare Techs?
Via Benzinga
Dow Giant Eyes Possible $10 Billion Spinoff; Is It The Next GE?
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
GE HealthCare to announce third quarter 2024 results on October 30, 2024
From GE HealthCare
Via Business Wire
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
From GE HealthCare
Via Business Wire
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
From GE HealthCare
Via Business Wire
The New Face of GE: Why Aerospace Might Be Worth the Wait
Via The Motley Fool
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 28
Via Talk Markets
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
From GE HealthCare
Via Business Wire
GE Vernova Is Up 22% This Month, But Analysts Still See Upside
Via Investor's Business Daily
GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare announces cash dividend for third quarter of 2024
From GE HealthCare Technologies Inc.
Via Business Wire
This GE HealthCare Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
Via The Motley Fool
GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024
From GE HealthCare
Via Business Wire
GE HealthCare management to present at September investor conferences
From GE HealthCare Technologies Inc.
Via Business Wire
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
From GE HealthCare
Via Business Wire
GE HealthCare to Embark on a Collaboration to Elevate Women’s Imaging
From GE HealthCare
Via Business Wire
Nvidia Looks To Disrupt The Health Care Industry With AI
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.